Previous close | 12.00 |
Open | 12.69 |
Bid | 12.10 |
Ask | 15.80 |
Strike | 230.00 |
Expiry date | 2024-06-21 |
Day's range | 12.00 - 13.24 |
Contract range | N/A |
Volume | |
Open interest | 204 |
RESEARCH TRIANGLE PARK, N.C., June 10, 2024--As cancer incidence continues to rise, it’s being met by wider use of innovative therapies and a robust pipeline of new drugs, according to a new report from the IQVIA Institute for Human Data Science titled, "Global Oncology Trends 2024: Outlook to 2028."
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Key Insights IQVIA Holdings' estimated fair value is US$325 based on 2 Stage Free Cash Flow to Equity IQVIA Holdings is...